Evaluation of Fluoxetine efficacy on change to side effect of ischemic strokes

Phase 2

Recruiting

• Conditions: Ischemic strokes.; Cerebellar stroke syndrome; G46.4*

• Registration Number: IRCT2017041720258N37
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

40-70 years; both of gender; lack of history ischemic strokes and nerve focal defect in last; nerve focal defect in recent ischemic strokes; compatibility clinical symptoms of stroke and place conflict brain imaging; select patient in 2-7 days after start ischemic strokes
Exclusion criteria: unavailability of patient during study period; history of side effect of Fluoxetine and other anti psychotic drugs; pregnant woman; lactating women; depression and recent depression in one month ago and treatment with anti psychotic drugs; use Monoamine oxidase inhibitorin five months ago

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change to side effect of stroke. Timepoint: start study and first one and two months after treatment?. Method of measurement: National Institutes of Health Stroke Scale questionnaire.